- Home
- SGMO vs CURR Comparison
SGMO vs CURR Comparison
Compare SGMO & CURR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SGMO | CURR |
|---|---|---|
| Founded | 1995 | 2013 |
| Country | United States | Singapore |
| Employees | 183 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 135.1M | 123.3M |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | SGMO | CURR |
|---|---|---|
| Price | $0.41 | $1.52 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $5.60 | $3.50 |
| AVG Volume (30 Days) | ★ 4.2M | 227.6K |
| Earning Date | 11-06-2025 | 11-01-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $32,875,000.00 | ★ $40,227,053.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $14.56 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.38 | $0.33 |
| 52 Week High | $1.40 | $4.68 |
Technical Indicators
Market Signals| Indicator | SGMO | CURR |
|---|---|---|
| Relative Strength Index (RSI) | 38.99 | 33.28 |
| Support Level | $0.43 | $1.56 |
| Resistance Level | $0.48 | $1.77 |
| Average True Range (ATR) | 0.03 | 0.16 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 8.32 | 3.45 |
Price Performance
Historical ComparisonAbout SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
About CURR Currenc Group Inc. Ordinary Shares
Currenc Group Inc is a fintech pioneer dedicated to transforming financial services through artificial intelligence (AI). It empowers financial institutions with comprehensive AI solutions, including the SEAMLESS AI Call Centre and other AI-powered tools designed to reduce costs, increase efficiency, and boost customer satisfaction. The Company's digital remittance platform also enables e-wallets, remittance companies, and corporations to provide real-time, 24/7 payment services, advancing financial access across underserved communities. It generates the majority of its geographic revenue from Malaysia.